Stevanato Group S.p.A. (NYSE:STVN) Receives Average Recommendation of “Moderate Buy” from Brokerages

Stevanato Group S.p.A. (NYSE:STVN) has earned a consensus recommendation of “Moderate Buy” from the five research firms that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold rating and four have issued a buy rating on the company.

Several brokerages recently commented on STVN. Wolfe Research began coverage on shares of Stevanato Group in a report on Friday. They set an “outperform” rating and a $28.00 target price for the company. Morgan Stanley reissued an “equal weight” rating and set a $23.00 target price (down previously from $24.00) on shares of Stevanato Group in a report on Tuesday, December 3rd. Finally, Bank of America raised their price target on shares of Stevanato Group from $24.00 to $26.00 and gave the stock a “buy” rating in a research report on Friday.

Hedge Funds Weigh In On Stevanato Group

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Conestoga Capital Advisors LLC lifted its holdings in shares of Stevanato Group by 5.5% during the third quarter. Conestoga Capital Advisors LLC now owns 7,675,910 shares of the company’s stock worth $153,518,000 after purchasing an additional 400,087 shares during the period. Thrivent Financial for Lutherans raised its position in Stevanato Group by 67.6% during the 3rd quarter. Thrivent Financial for Lutherans now owns 2,784,912 shares of the company’s stock worth $55,698,000 after purchasing an additional 1,123,104 shares during the last quarter. Wellington Management Group LLP lifted its holdings in Stevanato Group by 4.5% during the 3rd quarter. Wellington Management Group LLP now owns 2,693,588 shares of the company’s stock worth $53,872,000 after buying an additional 115,050 shares during the period. Bamco Inc. NY grew its position in shares of Stevanato Group by 1.3% in the 3rd quarter. Bamco Inc. NY now owns 1,685,181 shares of the company’s stock valued at $33,704,000 after buying an additional 21,469 shares during the last quarter. Finally, Fred Alger Management LLC increased its stake in shares of Stevanato Group by 24.2% in the third quarter. Fred Alger Management LLC now owns 1,070,557 shares of the company’s stock valued at $21,411,000 after buying an additional 208,830 shares during the period.

Stevanato Group Stock Performance

Shares of NYSE:STVN traded up €1.25 ($1.32) during trading on Friday, hitting €23.72 ($24.97). 471,347 shares of the company were exchanged, compared to its average volume of 500,527. Stevanato Group has a fifty-two week low of €16.56 ($17.43) and a fifty-two week high of €34.73 ($36.56). The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22. The firm has a fifty day moving average price of €19.58 and a two-hundred day moving average price of €19.65.

Stevanato Group (NYSE:STVN) last announced its quarterly earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) EPS for the quarter, missing analysts’ consensus estimates of €0.13 ($0.14) by (€0.01) (($0.01)). The firm had revenue of €277.90 million during the quarter, compared to analyst estimates of €274.36 million. Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The business’s revenue was up 2.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.16 EPS. On average, research analysts expect that Stevanato Group will post 0.5 EPS for the current fiscal year.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.